CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PW Medtech Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PW Medtech Group Ltd
Level 54
Hopewell Centre, 183 Queen's Road East
Phone: +86 1084783617p:+86 1084783617 BEIJING, BEJ  00000  China Ticker: 13581358

Business Summary
PW Medtech Group Ltd is a company principally engaged in the research and development (R&D) and sales of medical devices. The Company operates its businesses through three segments. Infusion Set Business segment is mainly engaged in the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. Blood Purification Business segment is mainly involved in the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. Regenerative Medical Biomaterials Business segment is mainly involved in the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The Company mainly operates its businesses in the domestic market.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Executive Chairman of the Board Yue'eZhang 58 3/31/2019 5/13/2013
Financial Director TianTian 39 1/1/2020 1/1/2020
Vice President YikunChen 45 1/1/2014 1/1/2014
7 additional Officers and Directors records available in full report.

Business Names
Business Name
1358
Beijing Fert Technology Co., Ltd.
Bone Medical Devices Co., Ltd.
PWE
Tianjin Walkman Biomaterial Co., Ltd.

General Information
Number of Employees: 1,302 (As of 6/30/2024)
Outstanding Shares: 1,491,854,098 (As of 11/29/2024)
Stock Exchange: HKG
Fax Number: +86 1084783657


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024